Equities researchers at DA Davidson raised their FY2026 earnings per share (EPS) estimates for Amplitude in a report issued on Tuesday, March 11th. DA Davidson analyst C. Wright now forecasts that the ...

Amplitude Surgical is a leading French player in the global market for surgical technologies for lower limb orthopaedics and ...

Amplitude (NASDAQ:AMPL – Get Free Report)‘s stock had its “buy” rating reissued by analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. They currently have a $16.

Brokerage firms remain divided on Zydus Lifesciences as the company announced to acquire France-based Amplitude Surgical for ...

India still relies largely on imported devices and implants, when it comes to MedTech. This offers us a great opportunity to ...

Piper Sandler analyst Brent Bracelin maintained a Buy rating on Amplitude (AMPL – Research Report) today and set a price target of $17.00. The ...

Meeting to be held in Boston on March 13 hosted by KeyBanc.Light Up your Portfolio with Spark:Easily identify stocks' risks and opportunities.

Zydus will file a mandatory cash tender offer for the remaining shares of Amplitude at the same purchase price of €6.25 per ...

Needham&Company reaffirmed its Buy rating on Amplitude shares following the company's investor day, highlighting innovations in AI, platform adoption, and enterprise growth.

Zydus Lifesciences on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based ...

Regulatory News: Zydus Lifesciences Limited2 ("Zydus"), a global innovation-driven lifesciences company has entered into exclusive negotiations to purchase3 from PAI Partners and Amplitude Surgical’s ...

Medical Technology includes medical devices and related scientific infrastructure that directly contribute to the development ...